Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 52 (3) , 417-424
- https://doi.org/10.1016/j.jhep.2009.09.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Adeno-Associated Virus Capsid Structure Drives CD4-Dependent CD8+ T Cell Response to Vector Encoded ProteinsThe Journal of Immunology, 2009
- Transcriptomic Effects of Tet-On and Mifepristone-Inducible Systems in Mouse LiverHuman Gene Therapy, 2008
- Gene therapy: Regulations, ethics and its practicalities in liver diseaseWorld Journal of Gastroenterology, 2008
- Liver transplantation for porphyria: Who, when, and how?Liver Transplantation, 2007
- Safety, Pharmacokinetics and Pharmocodynamics of Recombinant Human Porphobilinogen Deaminase in Healthy Subjects and Asymptomatic Carriers of the Acute Intermittent Porphyria Gene Who Have Increased Porphyrin Precursor ExcretionClinical Pharmacokinetics, 2007
- Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapyBlood, 2006
- Molecular mechanisms of dominant expression in porphyriaJournal of Inherited Metabolic Disease, 2005
- PorphyriasThe Lancet, 2005
- Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyriaMolecular Therapy, 2004
- Liver transplantation as a cure for acute intermittent porphyriaThe Lancet, 2004